Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Lumbar puncture, Lyme disease, Magnetic resonance imaging, Polymerase chain reaction, Positron emission tomogram
Clinical narrative: possible long COVID; possible long COVID; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 41-year-old female patient received BNT162b2 (BNT162B2), on 12Feb2021 at 13:00 as dose 1, single (Lot number: EN6201), in left arm and on 05Mar2021 at 13:00 as dose 2, single (Lot number: EN6205) at the age of 41 years, in left arm, all intramuscular for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications.  The following information was reported: DRUG INEFFECTIVE (medically significant), POST-ACUTE COVID-19 SYNDROME (medically significant) all with onset 2022, outcome "unknown" and all described as "possible long COVID". The patient underwent the following laboratory tests and procedures: Antinuclear antibody: (unspecified date) Normal; Blood glucose: (unspecified date) Normal; Coeliac disease: (17Jun2021) Normal; Computerised tomogram: (10May2021) Normal; C-reactive protein: (unspecified date) Normal; Cytokine test: (06Jul2021) elevated cytokines: 10-11; Electroencephalogram: (25May2021) Normal; (21Jul2021) Normal; HIV test: (17Jun2021) Normal; Endocrinology: (11May2021) Normal; (11Jan2022) Negative; (05May2021) Negative; (unspecified date) Auto immune condition; Lumbar puncture: (06Jul2021) high WBC, notes: Comment: high WBC -later explain due to prednisone; (21Jul2021) Normal; Lyme disease: (unspecified date) Normal; Magnetic resonance imaging: (20Apr2021) Normal; (20Jul2021) Normal; (04Aug2021) Normal; Polymerase chain reaction: (unspecified date) Normal; Positron emission tomogram: (07Jul2021) Normal; Protein total: (unspecified date) Normal; SARS-CoV-2 test: (2022) possible long COVID; Treponema test: (unspecified date) Normal; Ultrasound pelvis: (20Jul2021) Normal. Therapeutic measures were taken as a result of drug ineffective, post-acute covid-19 syndrome.  Clinical information:Vaccination facility type was public health clinic/administration facility. Vaccine administered at military facility was No. Test: lab,Date: 01Jun2021,Result: Normal. Test: C-reactive protein, ANA Screen, rickettsia , Lyme, refilter, rheumatoid ANCA,CMV PCR, VDRL, VEV, Glucose, protein all normal. Comments/Narrative:Patient was 41 years, white female PhD in clinical psychology No health problems. On 13Mar, 8 days after 2nd Pfizer vaccine she suffered short term memory loss, she also had headaches, brain Fogg, confusion. She has no recollection of the following 3 months. By mid Jun her memory improved to 75-80 headaches continued brain Fogg , confusion, kicked in head as well possible diagnosis autoimmune encephalitis post viral or vaccine injury. Later tests ruled out autoimmune condition. Prednisone treatment may explain improvement from mid Jun to mid Oct. but regression occurred there after. Nucleocapsid tests 05May2021-Negative , neutralization test 11Jan2022-negative. Cytokine panel reveals elevated cytokines: 10-11, VEGF, indicating vascular involvement due to sever anxiety, depression, suicidal thoughts, she is taking fluvoxamine , Buspar, Klonopin. She weighs withheld, random meds taken to address possible long COVID or vaccine injury include pravastatin , levothyroxine Naltrexone , cetirizine, famotidine , fish oil , B2, B12, D,C Magnesium. Starting a trail of maraviroc she is very sick with diagnosis. Please help